ANAHEIM, CA — Switching to clopidogrel postdischarge after starting on a more potent P2Y12 inhibitor as part of dual antiplatelet therapy (DAPT) after primary PCI apparently doesn’t lead to a greater risk of ischemic events over a year, at least in …
prague – BingNews